HUMANIZED MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-5

• 1. 人源抗白细胞介素5单克隆抗体及其制备方法和包含这些抗体的组合物 [P] . 中国专利： CN1326879C . 2007.07.18
• 2. 人源抗白细胞介素5单克隆抗体及其制备方法和包含这些抗体的组合物 [P] . 中国专利： CN1656122A . 2005-08-17
• 3. Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 (Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5) [P] . 韩国专利： KR1019957000413A . 1995-01-16

  机译： 抗人白介素5的人源化单克隆抗体的设计，克隆和表达（抗人白介素5的人源化单克隆抗体的设计，克隆和表达）

• 4. Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 [P] . 美国专利： US6451982B1 . 2002-09-17

  机译： 抗人白介素5的人源化单克隆抗体的设计，克隆和表达

• 5. Humanized monoclonal antibodies against human interleukin-5 [P] . IL104620A . 2000-02-29

  机译： 抗人白介素5的人源化单克隆抗体

• 1. Specific Immunotherapy in Advanced Cervical-Uterine Cancer Using Humanized Monoclonal Antibody Nimotuzumab and CIMAvax-EGF®;Therapeutic Vaccine [J] . Raiza Ruiz-Lorente, Sayly Alfonso, Eduardo Santiesteban, 癌症治疗（英文） . 2021,第003期
• 2. Deglycosylation Study of Murine IgG1, IgG2a, IgG2b, and Humanized IgG1 Monoclonal Antibodies [C] . Megan Ellis, John Lambert, Alexandru C. Lazar American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011
• 3. Humanization of a MUC16-Specific Monoclonal Antibody and Characterization of the MUC16 Epitope [D] . White, Brandy R. 2019
• 4. The Irony of Humanization: Alemtuzumab the First But One of the Most Immunogenic Humanized Monoclonal Antibodies [O] . David Baker, Liaqat Ali, Gauri Saxena, 2020
• 5. Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma [O] . Rhona Stein, Zhengxing Qu, Susan Chen, 2004

• 1. Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions [J] . Bohua ,Li ,Hao . 中国生物学文摘 . 2006,第001期
• 2. Induction of Human Anti-Human Antibody Responses (Ab2) after Application of a Humanized Lewis Y Carbohydrate Specific Antibody (Ab1): Connection of Prolonged Disease Stabilization with Ab3 Induction? [J] . Andreas Nechansky ,Stefan Stranner ,Oliver Scheiber . 癌症治疗（英文） . 2012,第4期
• 3. Preparation and activity analysis of the divalent and tetravalent humanized V_H single domain antibody against human lung cancer [J] . JIE PING WANG ,JIANG HUA YAN ,CHANG GONG ZHANG . 中华微生物学和免疫学：英文版 . 2007,第2期
• 4. Anti-Proliferative Effects Induced by Anti-CD4 Human/Murine Chimeric Antibody and Murine Anti-CD4 Monoclonal Antibody [J] . 沈关心 ,朱慧芬 ,王晓林 . 华中科技大学学报：医学英德文版 . 1999,第001期
• 5. 注射用人源化抗人TNF-α单克隆抗体在中国健康成年志愿者中抗药性抗体的产生对其药代动力学行为的影响 [C] . ZHANG Tan ,张坦 ,祖丽安 . 2018年中国药学会药物临床评价研究专业委员会学术年会暨临床研究高峰论坛 . 2018
• 6. 抗Aβ鼠源单克隆抗体的人源化改造及其表达鉴定 [A] . 李彦玮 . 2010